Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2000
05/10/2000EP0998564A1 Mcp-1 analogs
05/10/2000EP0998561A1 Trail receptor
05/10/2000EP0998560A1 Modified lepidopteran receptors and hybrid multifunctional proteins for use in regulation of transgene expression
05/10/2000EP0998559A1 Mammalian secretory peptide-9
05/10/2000EP0998558A1 Wa545 compositions
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998495A1 Amyloid beta protein (globular assembly and uses thereof)
05/10/2000EP0998494A1 Pompilid wasp-derived neuropeptides
05/10/2000EP0998492A1 Composition and methods for the treatment of inflammatory diseases
05/10/2000EP0998490A2 Secreted proteins and polynucleotides encoding them
05/10/2000EP0998488A1 Polyol-amino acid compounds having anti-helicobacter pylori activity
05/10/2000EP0998312A2 Compositions for morphogen-induced osteogenesis
05/10/2000EP0998307A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF
05/10/2000EP0998305A2 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
05/10/2000EP0998300A1 Methods and compositions for modulating responsiveness to corticosteroids
05/10/2000EP0998299A1 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF
05/10/2000EP0998298A2 Method of an increasing the antigen presenting ability of monocytes
05/10/2000EP0998297A2 Improved delivery of disease modifiers
05/10/2000EP0998282A1 Sulfonamides as cell adhesion inhibitors
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000EP0998275A1 INHIBITION OF NUCLEAR TRANSCRIPTION FACTOR NF-kappaB BY CAFFEIC ACID PHENETHYL ESTER (CAPE), DERIVATIVES OF CAPE, CAPSAICIN (8-METHYL-N-VANILLYL-6-NONENAMIDE) AND RESINIFERATOXIN
05/10/2000EP0998274A2 Microdose therapy of vascular conditions by no donors
05/10/2000EP0998251A2 Compositions and methods for inhibiting photoaging of skin
05/10/2000EP0623019B1 Docosahexaenoic acid based drugs, for use as platelet aggregation inhibitors and against essential fatty acid deficiencies of the brain, and preparation processes.
05/10/2000EP0602172B1 A method for treatment of patients with chronic liver disease
05/10/2000CN1252840A Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof
05/10/2000CN1252837A Compounds for immunotherapy of prostate cancer and methods for their use
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252808A Antipathogenic synthetic piptides and compositions comprising them
05/10/2000CN1252807A Neoglycoproteins
05/10/2000CN1252806A Dolastatin-15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus
05/10/2000CN1252729A Production process for intravenous immune serum globulin and resultant product
05/10/2000CN1252728A Dolastatin-15 derivatives in combination with taxanes
05/10/2000CN1252727A Method and composition for treating sleep apnea
05/10/2000CN1252726A Methods for treating vascular disorders
05/10/2000CN1252719A Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
05/10/2000CN1252712A Use of micro particles having a protein and an antibody adsorbed thereon for preparing a pharmaceutical composition for intranasal administration
05/10/2000CN1252695A Process for preparing a nutritional supplement
05/10/2000CN1252689A Combined tumor suppressor gene therapy and chemotherapy in treatment of neoplasms
05/10/2000CN1252307A AIDS vaccine injecta
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/10/2000CN1052239C Method for preparation of NTPS
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060589 Agouti-related proteins
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060582 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
05/09/2000US6060513 Compounds and compositions for delivering active agents
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/09/2000US6060462 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes
05/09/2000US6060460 Use of betaglycan to reduce scarring
05/09/2000US6060456 Chimeric oligonucleoside compounds
05/09/2000US6060452 Angiogenesis inhibitors; immunomodulators
05/09/2000US6060451 Thrombin inhibitors based on the amino acid sequence of hirudin
05/09/2000US6060450 Administering tau-interferon to treat multiple sclerosis, rheumatoid arthritis, diabetes, and lupus
05/09/2000US6060449 Neovascularization inhibitor containing tissue factor pathway inhibitor
05/09/2000US6060447 Genetic engineering, gene expression; adminstering as coagulant
05/09/2000US6060446 Protein and carnosine, glutathione, and/or cyclo-histidine-proline
05/09/2000US6060310 Transcription factor decoy and tumor growth inhibitor
05/09/2000US6060307 Amino acid transporters and uses
05/09/2000US6060303 Use in screening assays and as pharmaceuticals.
05/09/2000US6060302 Human phospholipase C-α and DNA sequence encoding the same
05/09/2000US6060300 Thrombin muteins as antidotes for thrombin inhibitors
05/09/2000US6060297 Rho protein
05/09/2000US6060296 Protein kinases
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060284 Polynucleotide coding for antigenic polypeptides of specific amino acid sequences; for diagnosis and therapy of immune and autoimmune disorders; polymerase chain reaction primers; hybridization probes
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060279 Interferon-α-induced protein
05/09/2000US6060278 Expressing recombinant human troponin c and t and a modified recombinant troponin i, then complexing by mixing in neutral ph, aqueous medium in presence of alkaline salt(s); for controls/calibrators in diagnosis of myocardial infarction
05/09/2000US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals
05/09/2000US6060275 Sprouty protein and coding sequence
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060270 Central lumen bordered by polarized epithelium and produced by culturing in all-trans retinoic acid, transforming growth factor-beta-1 and either epidermal growth factor or transforming growth factor-alpha; for kidney disorders
05/09/2000US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle
05/09/2000US6060258 With isoelectric point at 6.8 to 7.0 and molecular weight of 50 to 80 kilodaltons, inhibits apoptosis by decreasing cd16 expression, induces expression of cd11b, does not bind to heparin; as prognostic agent
05/09/2000US6060250 Human transferases
05/09/2000US6060247 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/09/2000US6060244 Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
05/09/2000US6060241 Compositions and methods relating to drug discovery and detection and treatment of gastrointestinal diseases
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060238 Method and composition for regulating apoptosis
05/09/2000US6060082 Phospholipid bilayer having covalently bonded phospholipids, an aqueous core and a lectin wherein the lectin is ulex europeans agglutinin i.
05/09/2000US6060071 Ectoin and ectoin derivatives as moisturizers in cosmetics
05/09/2000US6060068 Human IL-2 as a vaccine adjuvant
05/09/2000US6060066 First unit containing ricin toxoid vaccine and adjuvant and a second unit comprising a tumor-killing effective amount of ricin in sterile saline.
05/09/2000US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
05/09/2000US6060059 Haemophilus adhesion proteins
05/09/2000US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite)
05/09/2000US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
05/09/2000US6060055 Inducing immunological response in a mammal which comprises delivering a nucleic acid vector to direct expression of div1b polypeptide for expressing said div1b polypeptide in vivo
05/09/2000US6060052 Expanding primitive stem cells for restoration of hematopoietic capabilities and for providing modified human stem cells for gene therapy applications; transplantation of human hematopoietic stem cells
05/09/2000US6060051 Strain of bacillus for controlling plant diseases and corn rootworm
05/09/2000US6060048 Method for transplanting cells into the brain and therapeutic uses therefor
05/09/2000US6060047 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000US6060023 Molecular sensing apparatus
05/09/2000CA2153584C Cytokine restraining agents
1 ... 2395 2396 2397 2398 2399 2400 2401 2402 2403 2404 2405 2406 2407 2408 2409 2410 2411 2412 2413 2414 2415 ... 3163